Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit
J Allergy Clin Immunol Pract
.
2020 Mar;8(3):1126-1128.e1.
doi: 10.1016/j.jaip.2019.09.022.
Epub 2019 Oct 3.
Authors
David Vyles
1
,
Asriani Chiu
2
,
John Routes
2
,
Mariana Castells
3
,
Elizabeth J Phillips
4
,
Alexis Visotcky
5
,
Raphael Fraser
5
,
Liliana Pezzin
6
,
David C Brousseau
7
Affiliations
1
Pediatric Emergency Medicine, Medical College of Wisconsin, Milwaukee, Wis. Electronic address:
[email protected]
.
2
Allergy and Immunology, Medical College of Wisconsin, Milwaukee, Wis.
3
Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
4
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.
5
Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wis.
6
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wis.
7
Pediatric Emergency Medicine, Medical College of Wisconsin, Milwaukee, Wis.
PMID:
31586667
PMCID:
PMC7332348
DOI:
10.1016/j.jaip.2019.09.022
No abstract available
MeSH terms
Amoxicillin*
Child
Emergency Service, Hospital*
Humans
Infant
Substances
Amoxicillin
Associated data
ClinicalTrials.gov/NCT03404804
Grants and funding
P50 GM115305/GM/NIGMS NIH HHS/United States